FindTrial
Sign In

Exendin-(9-39)

DRUG6 trials

Sponsors

Diva De Leon, The University of Texas Health Science Center at San Antonio

Conditions

Congenital HyperinsulinismGastric BypassHypoglycemiaHypoglycemia After Gastric BypassPost Bariatric SurgeryPost BariatricsurgeryPost-bariatric SurgeryPostprandial Hypoglycemia

Early Phase 1

Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
RecruitingNCT00992901
The University of Texas Health Science Center at San AntonioHypoglycemia, Post Bariatricsurgery
Start: 2009-10-31End: 2027-08-31Target: 160Updated: 2025-09-09
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
RecruitingNCT01803451
The University of Texas Health Science Center at San AntonioPost-bariatric Surgery
Start: 2005-11-30End: 2027-08-31Target: 80Updated: 2025-09-09
The Effects of Bariatric Surgeries on Glucose Metabolism
RecruitingNCT02823665
The University of Texas Health Science Center at San AntonioGastric Bypass, Hypoglycemia After Gastric Bypass, Post Bariatric Surgery +1
Start: 2015-07-31End: 2027-08-31Target: 200Updated: 2025-09-09

Phase 1

Effect of Exendin-(9-39) on Glycemic Control in Subjects With Congenital Hyperinsulinism
CompletedNCT00571324
Diva De LeonCongenital Hyperinsulinism
Start: 2007-08-31End: 2014-12-31Updated: 2017-12-11
Effect of Exendin-(9-39) on Fasting Adaptation and Protein Sensitivity
CompletedNCT00897676
Diva De LeonCongenital Hyperinsulinism
Start: 2009-05-31End: 2017-01-31Updated: 2020-03-13

Unknown Phase

Role of Glucagon-Like Peptide-1 in Postprandial Hypoglycemia
CompletedNCT01162499
Diva De LeonPostprandial Hypoglycemia
Start: 2010-04-30End: 2014-12-31Updated: 2017-10-23

Related Papers

Blockade of glucagon-like peptide 1 receptor corrects postprandial hypoglycemia after gastric bypass.
2013-12-04196 citations